
Actos Significantly Decreases Alzheimer’s Risk
Diabetics get a lot more dementia than the average person. Yet diabetics taking FDA-approved Actos get a lot LESS dementia than the average person – 47% less. That’s about half the rate. Find out more.

Diabetics get a lot more dementia than the average person. Yet diabetics taking FDA-approved Actos get a lot LESS dementia than the average person – 47% less. That’s about half the rate. Find out more.

VIDEO + ARTICLE: Diagnostic technology is a powerful weapon in the fight against dementia. Find out how a new map of the ageing brain will

A startling new link shows Alzheimer’s in transplant patients is significantly lower, in fact almost absent, when compared to national data from the general population.

Lymphatic systems serve many tasks, including the draining of waste proteins. A unexpected new discovery found it reaches brain cells. Can it be boosted to

VIDEO + ARTICLE: A new epilepsy drug could be used to treat Alzheimer’s patients. Find out about this new experimental approach.

MEDICATION TRIALS: Although Astra Zeneca’s AZD05030 disappointed cancer researchers, it surprisingly blocked the damage caused by Alzheimer’s plaque. Learn about the speed with which this

VIDEO + ARTICLE: For 25 years, researchers tried curing Alzheimer’s by clearing amyloid plaque. While plaque is a problem, is it merely Alzheimer’s cargo, while

VIDEO: “For the first time I think we have a chance to really change the course of Alzheimer’s disease,” says Dr. Reisa Sperling. She’s leading

VIDEO & ARTICLE: CNBC’s Meg Tirrell reports on Biogen’s experimental drug for Alzheimer’s and how the company appears to have exceeded expectations.

VIDEO + ARTICLE: Earth’s gravity causes Alzheimer’s fibers to settle in the lab, before they can tangle. This is a big block in the search

Interestingly, loving care does not require twice the time. But it does require twice the presence.

A powerful song about an 80-year-old professor losing memory due to Alzheimer’s. A tribute and a call for understanding, love, and support.

The European Union authorizes Leqembi as its very first Alzheimer’s drug to target an underlying cause of Alzheimer’s.

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?

An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?

Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
No spam, only news and updates.



This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. It has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor